selected scholarly activity
-
journal articles
- Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non‐small cell lung cancer (NSCLC) through inhibition of HIF‐1α. Molecular Oncology. 17:2235-2256. 2023
- The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy. Communications Biology. 6:919. 2023
- Combination of an ACLY inhibitor with a GLP-1R agonist exerts additive benefits on nonalcoholic steatohepatitis and hepatic fibrosis in mice. Cell Reports Medicine. 4:101193-101193. 2023
- Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia. Cell Metabolism. 34:919-936. 2022
- Metformin-induced reductions in tumor growth involves modulation of the gut microbiome. Molecular Metabolism. 61:101498-101498. 2022
- The pesticide chlorpyrifos promotes obesity by inhibiting diet-induced thermogenesis in brown adipose tissue. Nature Communications. 12:1-12. 2021
- Bone cancer-induced pain is associated with glutamate signalling in peripheral sensory neurons. Molecular Pain. 16:1744806920911536-1744806920911536. 2020
- Monoamine oxidase-A activity is required for clonal tumorsphere formation by human breast tumor cells. Cellular and Molecular Biology Letters. 24:1-13. 2019
- Optimization of reverse osmosis flowback water treatment using halotolerant microbes naturally enriched in fractured shales. University of Ottawa Science Undergraduate Research Journal. 1:60-60. 2018